Skip to main content
42°
Clear
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
League of Women Voters SRI
League of Women Voters WS
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Sohm Inc
(OP:
SHMN
)
0.0011
UNCHANGED
Streaming Delayed Price
Updated: 1:09 PM EST, Nov 8, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Sohm Inc
< Previous
1
2
3
Next >
SOHM OTC Self-care Launches Suite of 13 New SOHM Nutrients’ Brand Chewables
November 14, 2023
From
SOHM, Inc.
Via
GlobeNewswire
BioMedNewsBreaks – SOHM Inc.’s (SHMN) ABBIE Technology Poised to Make a Difference in the Lives of Millions
November 09, 2023
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
Meta-Analysis Says Nutraceuticals Show Potential in Acne Treatment
November 08, 2023
Via
Investor Brand Network
SOHM, Inc. (SHMN) Completes Acquisition of ABBIE Gene-editing Tech, Begins Preparations to Commercialize Solutions for Heart Disease
October 19, 2023
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
SOHM Inc. Announces the Closure of Finances-Funding for its Various Projects
July 25, 2023
Via
ACCESSWIRE
SOHM Inc. Signed an Exclusive Distribution Agreement with India-based Stallion Laboratories Pvt. Ltd. for Levetiracetam for the Treatment of Epilepsy
April 26, 2023
Via
ACCESSWIRE
SOHM, Inc. (SHMN) Bolsters Executive Team; Confident About Anticipated Developments and Opportunities
October 17, 2023
Via
Investor Brand Network
BioMedNewsBreaks – SOHM, Inc. (SHMN), UACI Collaborate to Advance ABBIE, a Groundbreaking Non-Viral Gene-Editing Technology
October 10, 2023
Via
Investor Brand Network
SOHM Collaborates with University of Arizona Center for Innovation to Advance ABBIE, a Groundbreaking Non-Viral Gene-Editing Technology
October 10, 2023
From
SOHM, Inc.
Via
GlobeNewswire
BioMedNewsBreaks – SOHM, Inc. (SHMN) Announces Acquisition of World-Class Gene-Editing Platform
September 26, 2023
Via
Investor Brand Network
SOHM Announces Its Acquisition of ABBIE, a World-Class Gene-Editing Platform Which Can Deliver Genetic Payloads Using Non-Viral Vectors
September 26, 2023
From
SOHM, Inc.
Via
GlobeNewswire
BioMedNewsBreaks — SOHM Inc. (SHMN) Expands Team to Direct Global Growth Strategy
September 22, 2023
Via
Investor Brand Network
Generic Drug Manufacturer SOHM, Inc. (SHMN) Building Regenerative Medicine Platform with LOI for Gene Editing Technology
September 20, 2023
Via
Investor Brand Network
Topics
Economy
Exposures
Supply Chain
Leadership Changes At SOHM, Inc. (SHMN) to Strengthen Growth Strategies for Generic Drug Market and Gene Editing Platform Development
September 14, 2023
Via
Investor Brand Network
BioMedNewsBreaks – SOHM Inc. (SHMN) Names Seasoned Veteran as VP of Quality
September 11, 2023
Via
Investor Brand Network
SOHM, Inc. Announces the Appointment of Wm. Dewey Rushing as VP of Quality with Immediate Effect
September 11, 2023
From
SOHM, Inc.
Via
GlobeNewswire
BioMedNewsBreaks – SOHM, Inc. (SHMN) Announces Strategic Board Appointment of Dr. Krishna Bhat, MD, Ph.D., FACC
August 24, 2023
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
SOHM, Inc. Expands Its Advisory Board, Appointing Dr. Krishna Bhat, M.D, Ph.D., FACC, as Chief Medical Advisor
August 24, 2023
From
SOHM, Inc.
Via
GlobeNewswire
SOHM, Inc. Announce the Appointment of Dr. David Aguilar, Ph.D. as a Chief Operating Officer with the Company with Immediate Effect
August 08, 2023
Via
ACCESSWIRE
SOHM Inc. Signs LOI to Acquire Stem Cell Disruptive Technology and Patents
August 01, 2023
Via
ACCESSWIRE
SOHM, Inc. Introduces and Received Topical Skincare Line of Products Orders in Its Label
March 20, 2023
Via
ACCESSWIRE
SOHM, Inc. Signs MOU with London/Asia-Based Fund to Infuse Funds for Various Projects
October 18, 2022
Via
ACCESSWIRE
SOHM, Inc. Expands Advisory Board with Appointment of Dr. David Aguilar Ph.D., as its Expert Medical Advisor.
March 02, 2022
CHINO HILLS, CA / ACCESSWIRE / March 2, 2022 / SOHM, Inc. (OTC PINK:SHMN), a Pharmaceutical, Nutraceutical, and Cosmeceutical company that manufactures and markets generic drugs covering numerous...
From
SOHM, Inc.
Via
AccessWire
SOHM, Inc. Announces the Appointment of Wm. Dewey Rushing, former US FDA Investigator to its Advisory Board
February 23, 2022
CHINO HILLS, CA / ACCESSWIRE / February 23, 2022 / SOHM, Inc. (OTC PINK:SHMN), a Pharmaceutical, Nutraceutical, and Cosmeceutical company that manufactures and markets generic drugs covering numerous...
From
SOHM, Inc.
Via
AccessWire
Exposures
Product Safety
SOHM, Inc., Collaborates for Commercial Manufacturing of Brainwise(R), a Patented Omega 3 Formula for Global Distribution
November 30, 2021
This collaboration expands SOHM, Inc's manufacturing, and distribution footprint into Africa with an estimated $7,500,000 in revenue over 3 years. CHINO HILLS, CA / ACCESSWIRE / November 30, 2021 /...
From
SOHM, Inc.
Via
AccessWire
SOHM, Inc. Signs Industry Expert Sivana Group as Strategic Consultant for Rebranding and Global Expansion
November 15, 2021
SOHM, Inc. takes a step forward in achieving maximum value for their organizations' stakeholders with strategic rebranding and global expansion CHINO HILLS, CA / ACCESSWIRE / November 15, 2021 / SOHM,...
From
SOHM, Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
SOHM, Inc., Announces Important Details of Its California Pharmaceutical Company Acquisition Expanding Manufacturing into the US Market
November 11, 2021
Expanding SOHM, Inc's Pharmaceutical manufacturing capabilities under FDA licensing opens new opportunities for OTC, Cosmeceuticals, Veterinary, and Prescription Rx. CHINO HILLS, CA / ACCESSWIRE /...
From
SOHM, Inc.
Via
AccessWire
Exposures
Product Safety
SOHM, Inc., Signed a Definitive Agreement for Acquisition of Californian Pharmaceutical Company
September 30, 2021
SOHM, Inc. has taken a step forward in establishing its manufacturing base and network in the USA CHINO HILLS, CA / ACCESSWIRE / September 30, 2021 / SOHM, Inc. (OTC PINK:SHMN), a generic...
From
SOHM, Inc.
Via
AccessWire
Exposures
Product Safety
SOHM Receives Repeat New Order From Private Label Customer
September 29, 2021
SOHM also updates about new information and the new order CHINO HILLS, CA / ACCESSWIRE / September 29, 2021 / SOHM, Inc. (the "Company") (OTC PINK:SHMN), generic Pharmaceutical, Nutraceutical, and...
From
SOHM, Inc.
Via
AccessWire
SOHM, Inc. Moves a Step Closer in Securing a Definitive Agreement in Previously Announced Proposed Acquisition of Southern California Based Pharmaceutical Company
August 23, 2021
SOHM, Inc. takes a step forward in establishing its manufacturing base and network in the USA CHINO HILLS, CA / ACCESSWIRE / August 23, 2021 / SOHM, Inc. (OTC PINK:SHMN), a generic Pharmaceutical,...
From
Sohm, Inc.
Via
AccessWire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.